Last Updated：2025/11/25
The clinical trial reported that anatumomab mafenatox produced promising tumor reductions in patients with advanced non-small-cell lung cancer.
See correct answer
The clinical trial reported that anatumomab mafenatox produced promising tumor reductions in patients with advanced non-small-cell lung cancer.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
